Role of Ets/Id proteins for telomerase regulation in human cancer cells

Experimental and Molecular Pathology

Volumn 75, Issue 3, 2003, Pages 238-247

  Xiao, Xiaodong ^a   Athanasiou, Meropi ^a,b   Sidorov, Igor A ^a   Horikawa, Izumi ^c   Cremona, Gina ^a   Blair, Donald ^a   Barret, J Carl ^c   Dimitrov, Dimiter S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

C Myc; Ets; Id2; Sp1; Telomerase regulation

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; MYC PROTEIN; PROTEIN FLI1; PROTEIN MAD1; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL; CELL CLONE; CELL LYSATE; CELL STRAIN U937; CONTROLLED STUDY; ENZYME ACTIVITY; GEL; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR MECHANICS; MUTANT; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PURIFICATION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION SITE;

EID: 0242509786     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4800(03)00092-3     Document Type: Article

References (36)

1. Athanasiou M., Clausen P.A., Mavrothalassitis G.J., Zhang X.K., Watson D.K., Blair D.G. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 7:1996;1525-1534.
2. Athanasiou M., LeGallic L., Watson D.K., Blair D.G., Mavrothalassitis G. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids. Cancer Gene Ther. 7:2000;1188-1195.
3. Clausen P.A., Athanasiou M., Chen Z., Dunn K.J., Zhang Q., Lautenberger J.A., Mavrothalassitis G., Blair D.G. ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL. Leukemia. 11:1997;1224-1233.
4. Cong Y.S., Wen J., Bacchetti S. The human telomerase catalytic subunit hTERT organization of the gene and characterization of the promoter . Hum. Mol. Genet. 8:1999;137-142.
5. Cong Y.S., Wright W.E., Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66:2002;407-425. table.
6. Danos O., Mulligan R.C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges Proc . Natl. Acad. Sci. USA. 85:1988;6460-6464.
7. Drissi R., Zindy F., Roussel M.F., Cleveland J.L. c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells. J. Biol. Chem. 276:2001;29994-30001.
8. Ducrest A.L., Amacker M., Mathieu Y.D., Cuthbert A.P., Trott D.A., Newbold R.F., Nabholz M., Lingner J. Regulation of human telomerase activity repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity . Cancer Res. 61:2001;7594-7602.
9. Ducrest A.L., Szutorisz H., Lingner J., Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene. 21:2002;541-552.
10. Fu W., Lu C., Mattson M.P. Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. J. Neurosci. 22:2002;10710-10719.
11. Greenberg R.A., O'Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R., Lichtsteiner S., Chin L., Morin G.B., DePinho R.A. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene. 18:1999;1219-1226.
12. Greider C.W., Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 337:1989;331-337.
13. Gunes C., Lichtsteiner S., Vasserot A.P., Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res. 60:2000;2116-2121.
14. Hasskarl J., Munger K. Id proteins tumor markers or oncogenes . Cancer Biol. Ther. 1:2002;91-96.
15. Horikawa I., Cable P.L., Afshari C., Barrett J.C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59:1999;826-830.
16. Kyo S., Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells how can we apply them for cancer therapy . Oncogene. 21:2002;688-697.
17. Kyo S., Takakura M., Taira T., Kanaya T., Itoh H., Yutsudo M., Ariga H., Inoue M. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28:2000;669-677.
18. Lasorella A., Boldrini R., Dominici C., Donfrancesco A., Yokota Y., Inserra A., Iavarone A. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res. 62:2002;301-306.
19. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:2000;592-598.
20. Lasorella A., Uo T., Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene. 20:2001;8326-8333.
21. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45:1975;321-334.
22. Maida Y., Kyo S., Kanaya T., Wang Z., Yatabe N., Tanaka M., Nakamura M., Ohmichi M., Gotoh N., Murakami S., Inoue M. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene. 21:2002;4071-4079.
23. Maroulakou I.G., Bowe D.B. Expression and function of Ets transcription factors in mammalian development a regulatory network . Oncogene. 19:2000;6432-6442.
24. Miller A.D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:1986;2895-2902.
25. Moriuchi H., Moriuchi M., Arthos J., Hoxie J., Fauci A.S. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. J. Virol. 71:1997;9664-9671.
26. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., Sharrocks A.D., Peters G., Hara E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 409:2001;1067-1070.
27. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell. Biol. 2:2001;827-837.
28. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer. 33:1997;787-791.
29. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:1976;565-577.
30. Suzuki H., Romano-Spica V., Papas T.S., Bhat N.K. ETS1 suppresses tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci. USA. 92:1995;4442-4446.
31. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59:1999;551-557.
32. Won J., Yim J., Kim T.K. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J. 16:2002;1943-1945.
33. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21:1999;220-224.
34. Xiao X., Phogat S.K., Sidorov I.A., Yang J., Horikawa I., Prieto D., Adelesberger J., Lempicki R., Barrett J.C., Dimitrov D.S. Identification and characterization of rapidly dividing U937 clones with differential telomerase activity and gene expression profiles role of c-Myc/Mad1 and Id/Ets proteins . Leukemia. 16:2002;1877-1880.
35. Xu D., Popov N., Hou M., Wang Q., Bjorkholm M., Gruber A., Menkel A.R., Henriksson M. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. USA. 98:2001;3826-3831.
36. Zebedee Z., Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene. 20:2001;8317-8325.